The novel myosin activator, danicamtiv alters both systolic and diastolic functions in vitro and in vivo

被引：0
|
作者：
Raduly, A. [1 ]
Sarkany, F. [1 ]
Papp, Z. [1 ]
Toth, A. [1 ]
Csanadi, Z. [2 ]
Edes, I. [2 ]
Kovacs, M. [1 ]
Juhasz, B. [3 ]
Priksz, D. [3 ]
Borbely, A. [2 ]
机构：
[1] Univ Debrecen, Div Clin Physiol, Dept Cardiol, Fac Med, Debrecen, Hungary
[2] Univ Debrecen, Dept Cardiol, Fac Med, Debrecen, Hungary
[3] Univ Debrecen, Dept Pharmacol & Pharmacotherapy, Fac Med, Debrecen, Hungary
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2024年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：630 / 631
页数：2
相关论文
共 50 条
  • [41] The novel HSVtk mutant TK.007 shows superior performance both in vitro and in vivo
    Preuss, Ellen
    Treschow, Alexandra
    Newrzela, Sebastian
    Bruecher, Daniela
    Weber, Kristoffer
    Otte, Juergen
    Felldin, Ulrika
    Alici, Evren
    von Laer, Dorothee
    Dilber, Sirac
    Fehse, Boris
    HUMAN GENE THERAPY, 2009, 20 (11) : 1464 - 1464
  • [42] Zoledronate, a novel bisphosphonate, inhibits the growth of human leukemic cells both in vitro and in vivo.
    Kimura, S
    Kuroda, J
    Ottmann, OG
    Maekawa, T
    BLOOD, 2002, 100 (11) : 544A - 544A
  • [43] CDK7 inhibition is a novel therapeutic strategy against GBM both in vitro and in vivo
    Meng, Wei
    Wang, Jiajia
    Wang, Baocheng
    Liu, Fang
    Li, Meng
    Zhao, Yang
    Zhang, Chenran
    Li, Qifeng
    Chen, Juxiang
    Zhang, Liye
    Tang, Yujie
    Ma, Jie
    CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 5747 - 5758
  • [44] Novel Staphylococcus aureus Secreted Protein Alters Keratinocyte Proliferation and Elicits a Proinflammatory Response In Vitro and In Vivo
    Merriman, Joseph A.
    Klingelhutz, Aloysius J.
    Diekema, Daniel J.
    Leung, Donald Y. M.
    Schlievert, Patrick M.
    BIOCHEMISTRY, 2015, 54 (31) : 4855 - 4862
  • [45] Novel C5a receptor antagonists regulate neutrophil functions in vitro and in vivo
    Pellas, TC
    Boyar, W
    van Oostrum, J
    Wasvary, J
    Fryer, LR
    Pastor, G
    Sills, M
    Braunwalder, A
    Yarwood, DR
    Kramer, R
    Kimble, E
    Hadala, J
    Haston, W
    Moreira-Ludewig, R
    Uziel-Fusi, S
    Peters, P
    Bill, K
    Wennogle, LP
    JOURNAL OF IMMUNOLOGY, 1998, 160 (11): : 5616 - 5621
  • [46] Effects of novel Btk and Syk inhibitors on platelet functions alone and in combination in vitro and in vivo
    Series, Jennifer
    Ribes, Agnes
    Garcia, Cedric
    Souleyreau, Pierre
    Bauters, Anne
    Morschhauser, Franck
    Jurgensmeier, Juliane M.
    Sie, Pierre
    Ysebaert, Loic
    Payrastre, Bernard
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2020, 18 (12) : 3336 - 3351
  • [47] The effect of fenofibrate, a PPARα activator on toll-like receptor-4 signal transduction in melanoma both in vitro and in vivo
    Dana, N.
    Javanmard, S. Haghjooy
    Vaseghi, G.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2020, 22 (04): : 486 - 494
  • [48] The effect of fenofibrate, a PPARα activator on toll-like receptor-4 signal transduction in melanoma both in vitro and in vivo
    N. Dana
    S. Haghjooy Javanmard
    G. Vaseghi
    Clinical and Translational Oncology, 2020, 22 : 486 - 494
  • [49] The correlation between regional systolic-diastolic functions assessed by a novel program "cardioGRAF" and BNP in patients with non-ischemic CHF
    Takahashi, N
    Yamamoto, A
    Iwahara, S
    Tetsuka, S
    Takenaga, K
    Amitani, K
    Yamaguchi, T
    Uchida, T
    Hoshino, K
    Munakata, K
    JOURNAL OF CARDIAC FAILURE, 2005, 11 (09) : S304 - S304
  • [50] Effects of wortmannin, a novel myosin light-chain kinase inhibitor, on bile canalicular contraction in vitro and in vivo
    Suzuki, S
    Watanabe, S
    Hirose, M
    Kitamura, T
    Oide, H
    Sato, N
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1996, 31 (04) : 391 - 397
12345